Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report

RATIONALE: Immune checkpoint inhibitors are monoclonal antibodies used in the treatment of various types of cancers. The downside of using such molecules is the potential risk of developing immune-related adverse events. Factors that trigger these autoimmune side effects are yet to be elucidated. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyansky, Dimitry, Fallaha, Catherine, Gougeon, François, Pépin, Marie-Noëlle, Cailhier, Jean-François, Beaubien-Souligny, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
COVID-19 Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138284/
https://www.ncbi.nlm.nih.gov/pubmed/34046182
http://dx.doi.org/10.1177/20543581211014745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138284/
https://www.ncbi.nlm.nih.gov/pubmed/34046182
http://dx.doi.org/10.1177/20543581211014745

Ejemplares similares